SML2262

Ramelteon

Name: Ramelteon
Brand: SIGMA
Price: 142 USD
Availability: InStock

Synonym(s):

Ramelteon solution, (S)-N-[2-(1,6,7,8-Tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide, N-[2-[(8S)-1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl]propanamide, TAK 375, TAK-375

Slide 1 of 1

Select a Size

10 MG

$142.00

50 MG

$566.00

$142.00

Available to ship TODAYDetails

Request a Bulk Order

About This Item

Empirical Formula (Hill Notation):

C₁₆H₂₁NO₂

CAS Number:

196597-26-9

Molecular Weight:

259.34

UNSPSC Code:

12352200

NACRES:

NA.77

MDL number:

MFCD08067736

Form:

powder

Key Documents

View All Documentation

form

powder

optical activity

[α]/D -50 to -60°, c = 1.0 in chloroform-d

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

SMILES string

CCC(NCC[C@H]1C(C(CCO2)=C2C=C3)=C3CC1)=O

InChI

1S/C16H21NO2/c1-2-15(18)17-9-7-12-4-3-11-5-6-14-13(16(11)12)8-10-19-14/h5-6,12H,2-4,7-10H2,1H3,(H,17,18)/t12-/m0/s1

InChI key

YLXDSYKOBKBWJQ-LBPRGKRZSA-N

Gene Information

human ... MTNR1A(4543), MTNR1B(4544)

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item	SML1979	SML1217	SML1992
Sigma-Aldrich SML2262 Ramelteon	Sigma-Aldrich SML1979 FM-381	Sigma-Aldrich SML1217 TG4-155	Sigma-Aldrich SML1992 FM-479
form powder	form powder	form powder	form powder
storage temp. 2-8°C	storage temp. 2-8°C	storage temp. 2-8°C	storage temp. 2-8°C
solubility DMSO: 2 mg/mL, clear	solubility DMSO: 2 mg/mL, clear (warmed)	solubility DMSO: 20 mg/mL, clear	solubility DMSO: 2 mg/mL, clear
color white to beige	color white to beige	color white to beige	color yellow to orange
optical activity [α]/D -50 to -60°, c = 1.0 in chloroform-d	optical activity -	optical activity -	optical activity -
Gene Information human ... MTNR1A(4543), MTNR1B(4544)	Gene Information -	Gene Information -	Gene Information -

Biochem/physiol Actions

Ramelteon is a cell penetrant, potent and selective agonist at MT1/MT2 melatonin receptor that exhibits sleep-promoting properties. It is not binding to GABA receptor complex. Ramelteon is an analog of melatonin recently approved to treat insomnia.

pictograms

GHS07

signalword

Warning

hcodes

H302

pcodes

P264 - P270 - P301 + P312 - P501

Hazard Classifications

Acute Tox. 4 Oral

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

0000282346

0000194677

0000134144

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ramelteon Improves Post-traumatic Stress Disorder-Like Behaviors Exhibited by Fatty Acid-Binding Protein 3 Null Mice.

Yasushi Yabuki et al.

Molecular neurobiology, 55(4), 3577-3591 (2017-05-19)

We previously reported that fatty acid-binding protein 3 (FABP3) knockout (Fabp3

Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment.

Thomas Roth et al.

Sleep, 28(3), 303-307 (2005-09-22)

Evaluate the efficacy of ramelteon, an MT/1MT2-receptor agonist, for the treatment of transient insomnia in healthy adults. Randomized, double-blind, placebo-controlled design using a model of transient insomnia related to sleeping in a novel environment. Fourteen sleep research centers. Healthy adults

Melatonin Receptor Agonists as the "Perioceutics" Agents for Periodontal Disease through Modulation of Porphyromonas gingivalis Virulence and Inflammatory Response.

Wei Zhou et al.

PloS one, 11(11), e0166442-e0166442 (2016-11-11)

"Perioceutics" including antimicrobial therapy and host modulatory therapy has emerged as a vital adjunctive treatment of periodontal disease. Melatonin level was significantly reduced in patients with periodontal diseases suggesting melatonin could be applied as a potential "perioceutics" treatment of periodontal

Ramelteon ameliorated 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in neuronal cells in a mitochondrial-dependent pathway.

Chuo Li et al.

Bioengineered, 12(1), 4868-4877 (2021-08-05)

Parkinson's disease (PD) is a common neurodegenerative disease with global health and economic impact. 1-methyl-4-phenylpyridinium (MPP+)-induced mitochondrial dysfunction and oxidative stress are reported to participate in the pathological mechanism of PD. Ramelteon is a novel oral hypnotic agent that has

Global Trade Item Number

SKU	GTIN
SML2262-10MG	04061835369508
SML2262-50MG	04061835369515

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service